Xencor Inc (XNCR)
21.35
-0.16
(-0.74%)
USD |
NASDAQ |
Nov 05, 09:33
Xencor Enterprise Value: 839.10M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 839.10M |
| November 01, 2024 | 823.65M |
| October 31, 2024 | 808.19M |
| October 30, 2024 | 808.81M |
| October 29, 2024 | 842.81M |
| October 28, 2024 | 842.81M |
| October 25, 2024 | 817.46M |
| October 24, 2024 | 817.46M |
| October 23, 2024 | 813.13M |
| October 22, 2024 | 821.79M |
| October 21, 2024 | 812.52M |
| October 18, 2024 | 855.80M |
| October 17, 2024 | 829.83M |
| October 16, 2024 | 839.72M |
| October 15, 2024 | 815.61M |
| October 14, 2024 | 809.42M |
| October 11, 2024 | 825.50M |
| October 10, 2024 | 772.32M |
| October 09, 2024 | 724.09M |
| October 08, 2024 | 710.49M |
| October 07, 2024 | 713.58M |
| October 04, 2024 | 736.46M |
| October 03, 2024 | 713.58M |
| October 02, 2024 | 712.34M |
| October 01, 2024 | 723.47M |
| Date | Value |
|---|---|
| September 30, 2024 | 752.54M |
| September 27, 2024 | 761.19M |
| September 26, 2024 | 774.18M |
| September 25, 2024 | 730.90M |
| September 24, 2024 | 758.72M |
| September 23, 2024 | 763.05M |
| September 20, 2024 | 811.90M |
| September 19, 2024 | 819.94M |
| September 18, 2024 | 798.29M |
| September 17, 2024 | 810.04M |
| September 16, 2024 | 816.84M |
| September 13, 2024 | 836.63M |
| September 12, 2024 | 796.44M |
| September 11, 2024 | 815.61M |
| September 10, 2024 | 691.94M |
| September 09, 2024 | 738.93M |
| September 06, 2024 | 509.53M |
| September 05, 2024 | 518.19M |
| September 04, 2024 | 537.36M |
| September 03, 2024 | 556.52M |
| August 30, 2024 | 590.53M |
| August 29, 2024 | 579.40M |
| August 28, 2024 | 556.52M |
| August 27, 2024 | 568.89M |
| August 26, 2024 | 597.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
479.85M
Minimum
Aug 07 2024
2.515B
Maximum
Feb 08 2021
1.261B
Average
1.201B
Median
Jul 29 2022
Enterprise Value Benchmarks
| Biogen Inc | 29.88B |
| Dynavax Technologies Corp | 1.033B |
| SINTX Technologies Inc | -2.126M |
| Fulcrum Therapeutics Inc | -70.35M |
| Moderna Inc | 12.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -65.96M |
| Revenue (Quarterly) | 16.96M |
| Total Expenses (Quarterly) | 79.28M |
| EPS Diluted (Quarterly) | -1.07 |
| Profit Margin (Quarterly) | -388.9% |
| Earnings Yield | -13.54% |
| Normalized Earnings Yield | -11.38 |